Workflow
Drift
icon
Search documents
Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting
Prnewswire· 2025-08-08 21:00
Core Points - Aurora Cannabis Inc. held its Annual General and Special Meeting of Shareholders on August 8, 2025, with 17,736,521 common shares represented, accounting for 31.53% of the total issued shares [1] - The election results for the Board of Directors showed that all nominees, except for Theresa Firestone, were elected [2] - Following the meeting, Theresa Firestone resigned from the Board effective August 31, 2025, and Michael Singer was appointed as the new Lead Independent Director and Chair of the Human Resources and Compensation Committee [3][4] - Shareholders approved the appointment of Ernst & Young LLP as auditors and amendments to the Company's RSU Plan, PSU Plan, and Share Option Plan, but the advisory vote on executive compensation did not pass [5] Voting Results - Miguel Martin received 5,513,929 votes for his position, while Theresa Firestone received only 2,620,830 votes for her position, leading to her resignation [2][3] - The voting results indicate a strong preference for the other board nominees, with the highest votes for Michael Singer at 5,194,307 [2] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across multiple regions including Canada, Europe, Australia, and New Zealand [7] - The company offers a diverse portfolio of brands in both adult-use and medical cannabis markets, emphasizing high-quality products and innovation [7][8]
Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders
Prnewswire· 2025-07-30 11:05
Your vote is important no matter how many shares you own. Please vote today. Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1-877-452-7184 or by email at [email protected].EDMONTON, AB, July 30, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, would like to remind ...
Aurora Cannabis to Host First Quarter 2026 Investor Conference Call
Prnewswire· 2025-07-23 21:35
Core Viewpoint - Aurora Cannabis Inc. is set to announce its financial results for the first quarter of 2026 on August 6, 2025, and will host a conference call to discuss these results [1][5]. Group 1: Conference Call Details - The conference call is scheduled for August 6, 2025, at 8:00 a.m. Eastern Time and 6:00 a.m. Mountain Time [2]. - Miguel Martin, Executive Chairman and CEO, along with Simona King, CFO, will lead the conference call and Q&A session [2]. Group 2: Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Edmonton, Alberta, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [3]. - The company offers a diverse portfolio of brands, including adult-use brands like Drift and San Rafael '71, and medical brands such as MedReleaf and CanniMed [3]. - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [3]. Group 3: Stock Information - Aurora's common shares are traded on NASDAQ and TSX under the symbol "ACB" [4].
Aurora Cannabis Inc. (ACB) Announces Filing and Mailing of the Management Information
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-07-09 14:55
Core Points - Aurora Cannabis Inc. has filed and mailed the management information circular for the upcoming annual general and special meeting of shareholders [1] - The meeting is scheduled to be held virtually on August 8, 2025, at 1:00 p.m. Eastern time [2] - Shareholders are encouraged to vote their shares by the deadline of August 6, 2025, at 1:00 p.m. Eastern time [3] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company offers a diverse portfolio of adult-use and medical cannabis brands, including Drift, San Rafael '71, MedReleaf, and others [4] - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [4] Shareholder Engagement - Shareholders can access the management information circular on the company's website and are encouraged to watch a message from the CEO and CFO reflecting on fiscal 2025 [2] - The company emphasizes the importance of shareholder participation and provides contact information for assistance with voting [3]